Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration

Kim Cluff, Dimitrios Miserlis, Govindarajan Konda Naganathan, Iraklis I. Pipinos, Panagiotis Koutakis, Ashok Samal, Rodney D. McComb, Jeyamkondan Subbiah, George P. CasaleAmerican 2013 · DOI

TL;DR

This paper introduces a novel method for objectively grading muscle degeneration in patients with Peripheral Arterial Disease (PAD) by analyzing the morphometric features of gastrocnemius muscle biopsies. By developing a discriminant model based on these features, they achieved high accuracy in classifying patients into control, claudication, and critical limb ischemia (CLI) groups, offering a promising tool for disease staging and treatment guidance.

What Problem Does This Paper Address?

Peripheral Arterial Disease (PAD) is a widespread condition affecting millions, characterized by narrowed arteries that reduce blood flow, particularly to the legs. This chronic ischemia leads to progressive damage and degeneration of leg muscles, impacting patient mobility and quality of life. Current diagnostic methods for PAD primarily rely on clinical symptoms and hemodynamic measurements like the Ankle-Brachial Index (ABI). While these are valuable, they don't always capture the nuanced degree of muscle damage at the tissue level. Histological examination of muscle tissue has been largely qualitative, lacking objective metrics to grade the severity of degeneration. This gap makes it challenging to precisely assess disease progression and tailor treatment strategies. This study aims to bridge this gap by developing a quantitative, objective method to grade muscle degeneration in PAD patients using detailed analysis of muscle fiber morphology.

Methods

The researchers employed a multi-step approach to develop their grading system. First, they collected gastrocnemius muscle biopsies from three groups: healthy controls, patients with intermittent claudication (an early symptom of PAD), and patients with critical limb ischemia (CLI, a severe form of PAD). These biopsies were then processed for fluorescence labeling to visualize myofiber sarcolemmas and myosin heavy chains.

The core of their methodology lies in quantitative morphometric analysis. Using fluorescence microscopy and specialized image processing software, they extracted numerous parameters from individual muscle fibers. These included basic measurements like area, perimeter, and diameter, as well as shape descriptors such as roundness and solidity. They also calculated fiber density, representing the proportion of muscle tissue occupied by fibers versus interstitial space.

To create an objective grading system, they developed discriminant models using linear discriminant analysis. This statistical technique aims to find a mathematical rule that best separates different groups based on a set of variables. They split their data into training and validation sets. The models were trained to distinguish between control/claudicating patients and CLI patients (Model 1), and then between control and claudicating patients (Model 2). Key variables selected for these models included standard deviations of roundness and solidity, fiber density, and measures of fiber size (major/minor axes).

Datasets

The study utilized muscle biopsy samples from three distinct patient groups:

  • Control patients: 19 individuals without PAD.
  • Claudication patients: 18 individuals diagnosed with intermittent claudication.
  • Critical Limb Ischemia (CLI) patients: 19 individuals diagnosed with CLI.

These samples were divided into training and validation sets for developing and testing the discriminant models. The paper does not introduce new benchmark datasets but rather uses patient data collected for the study.

Key Insights and Ideas

  • Muscle morphology as a biomarker: The study powerfully demonstrates that subtle, quantifiable changes in muscle fiber shape and size directly correlate with the severity of PAD. This moves beyond purely functional or hemodynamic measures to a direct assessment of tissue health.
  • Objective grading is achievable: By leveraging advanced imaging and statistical modeling, the researchers have created a system that can objectively assign a "score" to muscle degeneration, moving away from subjective histological interpretations.
  • Early detection and intervention potential: The ability to differentiate between control, claudication, and CLI patients with high accuracy suggests this method could help identify patients at risk of progressing from claudication to CLI, potentially enabling earlier and more aggressive interventions.
  • The role of fiber shape and density: The discriminant models highlight the importance of not just fiber size but also how "round" or "solid" the fibers are, and the overall density of muscle tissue. These parameters likely reflect underlying cellular damage, fibrosis, and fat infiltration characteristic of PAD.

Key Results

The developed discriminant models demonstrated significant accuracy in classifying patients:

  • Model 1 (CLI vs. Control/Claudication): Achieved 100% accuracy in the training set and 88.8% accuracy for CLI patients and 100% for control/claudicating patients in the validation set.
  • Model 2 (Control vs. Claudication): Achieved 94.4% accuracy in the training set and 80.0% accuracy for controls and 77.7% for claudicating patients in the validation set.
  • Combined Models (Validation Set): An overall classification accuracy of 82.1% was achieved when combining the results of both models on the validation dataset.

Qualitatively, the study found that CLI patients exhibited significantly lower fiber density and greater variation in myofiber roundness and solidity compared to control/claudicating patients. This indicates more interstitial tissue (fibrosis/fat) and less regular fiber shapes in more severe PAD.

Limitations and Future Work

The authors acknowledge several limitations:

  • Observational nature: The study establishes correlations but does not definitively prove that observed muscle degeneration causes progression from claudication to CLI. Longitudinal studies are needed.
  • Sample size: The sample size, while reasonable for a pilot study, is not large enough to fully account for individual patient characteristics like comorbidities (e.g., diabetes) or activity levels.
  • Control group matching: While efforts were made, control subjects were not precisely matched for all comorbidities, medications, or activity levels, though they did have normal ABIs and led sedentary lifestyles.

Future work suggested includes:

  • Prospective natural history studies: To define the role of these tissue-based indices in patient care.
  • Incorporating other biomarkers: Adding measures of myofiber oxidative damage, inflammatory cytokines, and mitochondrial dysfunction could further enhance classification accuracy.
  • Predicting limb function: Evaluating the models' ability to predict objective biomechanical indicators of limb function.
  • Developing a comprehensive profile: Creating a more extensive profile of quantitative morphometric changes to guide diagnosis, staging, and intervention studies.

Summary updated

Abstract

Peripheral arterial disease (PAD), which affects ~10 million Americans, is characterized by atherosclerosis of the noncoronary arteries. PAD produces a progressive accumulation of ischemic injury to the legs, manifested as a gradual degradation of gastrocnemius histology. In this study, we evaluated the hypothesis that quantitative morphological parameters of gastrocnemius myofibers change in a consistent manner during the progression of PAD, provide an objective grading of muscle degeneration in the ischemic limb, and correlate to a clinical stage of PAD. Biopsies were collected with a Bergström needle from PAD patients with claudication (n = 18) and critical limb ischemia (CLI; n = 19) and control patients (n = 19). Myofiber sarcolemmas and myosin heavy chains were labeled for fluorescence detection and quantitative analysis of morphometric variables, including area, roundness, perimeter, equivalent diameter, major and minor axes, solidity, and fiber density. The muscle specimens were separated into training and validation data sets for development of a discriminant model for categorizing muscle samples on the basis of disease severity. The parameters for this model included standard deviation of roundness, standard deviation of solidity of myofibers, and fiber density. For the validation data set, the discriminant model accurately identified control (80.0% accuracy), claudicating (77.7% accuracy), and CLI (88.8% accuracy) patients, with an overall classification accuracy of 82.1%. Myofiber morphometry provided a discriminant model that establishes a correlation between PAD progression and advancing muscle degeneration. This model effectively separated PAD and control patients and provided a grading of muscle degeneration within clinical stages of PAD.
BibTeX
@inproceedings{cluff2013morphometric,
  author = {Kim Cluff and Dimitrios Miserlis and Govindarajan Konda Naganathan and Iraklis I. Pipinos and Panagiotis Koutakis and Ashok Samal and Rodney D. McComb and Jeyamkondan Subbiah and George P. Casale},
  title = {{Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration}},
  booktitle = {American},
  year = {2013},
  doi = {10.1152/ajpregu.00525.2012},
}
Figure